Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Akira Mogi

Showing results (71-80 of 92) with videos related to

Pageof 10
Sort By:
Annals of Surgical Oncology|March 30, 2019
Genetic and Immunohistochemical Studies Investigating the Histogenesis of Neuroendocrine and Carcinomatous Components of Combined Neuroendocrine CarcinomaMisaki Iijima, Takehiko Yokobori, Akira Mogi, et al.
The American Surgeon|April 22, 2004
Body fat accumulation and postoperative complications after abdominal surgeryKatsuhiko Tsukada, Tatsuya Miyazaki, Hiroyuki Kato, et al.
Anticancer Research|December 29, 2018
Prognostic Impact of β2 Adrenergic Receptor Expression in Surgically Resected Pulmonary Pleomorphic CarcinomaKyoichi Kaira, Mitsuhiro Kamiyoshihara, Osamu Kawashima, et al.
Molecular Cancer Research : MCR|October 30, 2013
FBXW7 mediates chemotherapeutic sensitivity and prognosis in NSCLCsTakehiko Yokobori, Yozo Yokoyama, Akira Mogi, et al.
World Journal of Surgery|October 7, 2017
Clinical and Radiological Discrimination of Solitary Pulmonary Lesions in Colorectal Cancer PatientsYoichi Ohtaki, Kimihiro Shimizu, Toshiteru Nagashima, et al.
The Annals of Thoracic Surgery|March 27, 2019
Stathmin-1 Is a Useful Diagnostic Marker for High-Grade Lung Neuroendocrine TumorsKimihiro Shimizu, Yusuke Goto, Reika Kawabata-Iwakawa, et al.
Clinical and Experimental Nephrology|September 1, 2017
Guidelines for treatment of renal injury during cancer chemotherapy 2016Shigeo Horie, Mototsugu Oya, Masaomi Nangaku, et al.
Cancers|October 27, 2019
Clinical Significance of Various Drug-Sensitivity Markers in Patients with Surgically Resected Pulmonary Pleomorphic CarcinomaHisao Imai, Kimihiro Shimizu, Osamu Kawashima, et al.
European Journal of Nuclear Medicine and Molecular Imaging|August 23, 2017
Metabolic activity by <sup>18</sup>F-FDG-PET/CT is predictive of early response after nivolumab in previously treated NSCLCKyoichi Kaira, Tetsuya Higuchi, Ichiro Naruse, et al.
Lung Cancer (Amsterdam, Netherlands)|April 17, 2018
Correlation of tumor-related immunity with 18F-FDG-PET in pulmonary squamous-cell carcinomaNorimitsu Kasahara, Kyoichi Kaira, Pinjie Bao, et al.
Pageof 10

Showing results (71-80 of 92) with videos related to

Sort By:
Pageof 10
Annals of Surgical Oncology|March 30, 2019
Genetic and Immunohistochemical Studies Investigating the Histogenesis of Neuroendocrine and Carcinomatous Components of Combined Neuroendocrine CarcinomaMisaki Iijima, Takehiko Yokobori, Akira Mogi, et al.
The American Surgeon|April 22, 2004
Body fat accumulation and postoperative complications after abdominal surgeryKatsuhiko Tsukada, Tatsuya Miyazaki, Hiroyuki Kato, et al.
Anticancer Research|December 29, 2018
Prognostic Impact of β2 Adrenergic Receptor Expression in Surgically Resected Pulmonary Pleomorphic CarcinomaKyoichi Kaira, Mitsuhiro Kamiyoshihara, Osamu Kawashima, et al.
Molecular Cancer Research : MCR|October 30, 2013
FBXW7 mediates chemotherapeutic sensitivity and prognosis in NSCLCsTakehiko Yokobori, Yozo Yokoyama, Akira Mogi, et al.
World Journal of Surgery|October 7, 2017
Clinical and Radiological Discrimination of Solitary Pulmonary Lesions in Colorectal Cancer PatientsYoichi Ohtaki, Kimihiro Shimizu, Toshiteru Nagashima, et al.
The Annals of Thoracic Surgery|March 27, 2019
Stathmin-1 Is a Useful Diagnostic Marker for High-Grade Lung Neuroendocrine TumorsKimihiro Shimizu, Yusuke Goto, Reika Kawabata-Iwakawa, et al.
Clinical and Experimental Nephrology|September 1, 2017
Guidelines for treatment of renal injury during cancer chemotherapy 2016Shigeo Horie, Mototsugu Oya, Masaomi Nangaku, et al.
Cancers|October 27, 2019
Clinical Significance of Various Drug-Sensitivity Markers in Patients with Surgically Resected Pulmonary Pleomorphic CarcinomaHisao Imai, Kimihiro Shimizu, Osamu Kawashima, et al.
European Journal of Nuclear Medicine and Molecular Imaging|August 23, 2017
Metabolic activity by <sup>18</sup>F-FDG-PET/CT is predictive of early response after nivolumab in previously treated NSCLCKyoichi Kaira, Tetsuya Higuchi, Ichiro Naruse, et al.
Lung Cancer (Amsterdam, Netherlands)|April 17, 2018
Correlation of tumor-related immunity with 18F-FDG-PET in pulmonary squamous-cell carcinomaNorimitsu Kasahara, Kyoichi Kaira, Pinjie Bao, et al.
Pageof 10